Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

New drug could slow down progression of Alzheimer’s

Drug maker Biogen reported today at a major Alzheimer's conference that after 18 months of treatment, patients who received the highest dose saw a 30 percent reduction in memory and daily function decline, versus those given a placebo.

Best of NBC News

Play All